Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trodelvy
Pharma
Daiichi Sankyo reports solid launch for touted ADC Datroway
Daiichi Sankyo and AstraZeneca's TROP2-directed ADC Datroway is off to a "smooth market launch,” according to Daiichi CEO Hiroyuki Okuzawa.
Kevin Dunleavy
Apr 28, 2025 5:00pm
Gilead's Trodelvy-Keytruda proposal hits goal in first-line TNBC
Apr 21, 2025 11:29am
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
Jan 17, 2025 9:14pm
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
Dec 4, 2024 12:52pm
Kelun's Merck-partnered TROP2 ADC snags first nod in China
Nov 27, 2024 10:56am
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
